[Zollinger-Ellison syndrome associated with Cushing's syndrome in a child (author's transl)]. 1980

G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine

The Zollinger-Ellison syndrome with characteristic symptoms is described in an 11 year old girl. Coeliac and mesenteric arteriography showed a pancreatic gastrin-secreting tumor. After total gastrectomy the condition improved but the associated Cushing's syndrome deteriorated. Surgical removal of the tumor was not possible and the child was treated with chemotherapy (5-fluorouracil and cyclophosphamide) and OP'DDD.

UI MeSH Term Description Entries
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D010257 Paraneoplastic Syndromes In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. Paraneoplastic Syndrome,Syndrome, Paraneoplastic,Syndromes, Paraneoplastic
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D002445 Celiac Artery The arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries. Arteries, Celiac,Artery, Celiac,Celiac Arteries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
April 1982, La Nouvelle presse medicale,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
July 1986, The New England journal of medicine,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
October 1987, Gan no rinsho. Japan journal of cancer clinics,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
March 1989, Vestnik khirurgii imeni I. I. Grekova,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
January 1986, Journal of pediatric gastroenterology and nutrition,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
January 1976, Archives francaises des maladies de l'appareil digestif,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
June 1979, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
January 1976, Archives francaises des maladies de l'appareil digestif,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
October 1969, Gut,
G A Loeuille, and P Debeugny, and P Morel, and M Razemon-Pinta, and J Lefebvre, and J P Farriaux, and G Fontaine
August 1978, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Copied contents to your clipboard!